-
Recent studies indicate that semaglutide, marketed as Ozempic and Wegovy, may significantly reduce mortality rates and slow aging in overweight individuals with cardiovascular disease. The drug shows potential benefits beyond weight loss, including lower death rates from various causes, including COVID-19. These findings were presented at the European Society of Cardiology Conference.
-
A groundbreaking clinical trial for a pancreatic cancer vaccine has begun in Europe, with the first patient enrolled in Birmingham, UK. This trial aims to improve early diagnosis and treatment options for a disease known for its low survival rates. Experts express optimism about the vaccine's potential impact.
-
Recent developments in cancer treatment include a £42 million UK screening trial for prostate cancer and promising results from Moderna's mRNA-4359 jab for advanced cancers. These initiatives aim to improve early detection and treatment efficacy, potentially transforming patient outcomes.